Century Therapeutics, Inc. (IPSC) stock
IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.65+0.02 (+1.23%)
Close on Nov 13, 2026Market cap $298.77MP/E –Yield –
Century Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Century Therapeutics's total assets was $262.63M at Sep 30, 2026. For fiscal 2025 it was $223.70M, down 36.7% from the year before. The highest annual figure on record is $486.54M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $223.70M | -36.7% |
| FY2024 | Dec 31, 2024 | $353.22M | -2.1% |
| FY2023 | Dec 31, 2023 | $360.69M | -25.9% |
| FY2022 | Dec 31, 2022 | $486.54M | +11.2% |
| FY2021 | Dec 31, 2021 | $437.38M | +309.6% |
| FY2020 | Dec 31, 2020 | $106.78M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $262.63M | +7.3% |
| Q2 FY2026 | Jun 30, 2026 | $287.01M | +0.8% |
| Q1 FY2026 | Mar 31, 2026 | $326.55M | +3.5% |
| Q4 FY2025 | Dec 31, 2025 | $223.70M | -36.7% |
| Q3 FY2025 | Sep 30, 2025 | $244.72M | -37.0% |
| Q2 FY2025 | Jun 30, 2025 | $284.69M | -31.6% |
| Q1 FY2025 | Mar 31, 2025 | $315.61M | -9.4% |
| Q4 FY2024 | Dec 31, 2024 | $353.22M | -2.1% |
| Q3 FY2024 | Sep 30, 2024 | $388.62M | -2.2% |
| Q2 FY2024 | Jun 30, 2024 | $416.45M | -0.2% |
| Q1 FY2024 | Mar 31, 2024 | $348.51M | -23.6% |
| Q4 FY2023 | Dec 31, 2023 | $360.69M | -25.9% |
| Q3 FY2023 | Sep 30, 2023 | $397.55M | -22.3% |
| Q2 FY2023 | Jun 30, 2023 | $417.16M | -21.7% |
| Q1 FY2023 | Mar 31, 2023 | $456.23M | -17.1% |
| Q4 FY2022 | Dec 31, 2022 | $486.54M | +11.2% |
| Q3 FY2022 | Sep 30, 2022 | $511.75M | +8.9% |
| Q2 FY2022 | Jun 30, 2022 | $532.58M | +7.5% |
| Q1 FY2022 | Mar 31, 2022 | $550.31M | +415.4% |
| Q4 FY2021 | Dec 31, 2021 | $437.38M | – |
| Q3 FY2021 | Sep 30, 2021 | $469.73M | – |
| Q2 FY2021 | Jun 30, 2021 | $495.63M | – |
| Q4 FY2020 | Dec 31, 2020 | $106.78M | – |
See a number that looks wrong?